Tellurian shares are trading higher Tuesday amid reports that the company is in talks with Saudi Aramco and Woodside Energy Group Ltd.to invest in its liquefied natural gas export project in Louisiana.
On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE:
Key Takeaways:
EDA’s revenue rose 71% last year on strong demand for its logistics services for Chinese cross-border e-commerce merchants
The company’s “pre-sale stocking model” could give it an advantage as the direct-shipping model used by rivals Temu and Shein comes under fire in the U.S.
Key Takeaways:
Smart Share Global’s revenue plunged more than 50% in the first quarter, as revenue from its core charging services tumbled amid its business transformation
The company is gradually shifting operational responsibilities for its network of Energy Monster power bank cabinets to third-party business partners
In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024.
The report highlights a deceleration in market growth and notable shifts in sales dynamics among leading licensed producers (LPs).
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption (IDE) application for its LIBERTY Endovascular Robotic Surgical System.